Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients - Wikidata - wikimedia - TriplyDB

Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients

Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients

http://www.wikidata.org/entity/Q36379615

about

Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases Society of America.Cardiovascular disease risk in an aging HIV population: not just a question of biology.Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients.Short Communication: Viral Suppression Is Associated with Increased Likelihood of Colorectal Cancer Screening Among Persons Living with HIV/AIDS.Low-dose aspirin (acetylsalicylate) prevents increases in brain PGE2, 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats, a model for HIV-1 associated neurocognitive disorders.Coronary artery disease risk reduction in HIV-infected persons: a comparative analysis.The next therapeutic challenge in HIV: polypharmacy.Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population.The Aspirin Foundation Scientific Conference: the history, the present state and the future of aspirin prophylaxis.Cardiovascular disease and HIV infection.Risk of coronary heart disease in patients with HIV infection.Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer.Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.Heart failure in patients with human immunodeficiency virus infection: Epidemiology and management disparities.Graying of the HIV epidemic: a challenge for inpatient medicine providers.Use of aspirin and statins for the primary prevention of myocardial infarction and stroke in patients with human immunodeficiency virus infection.HIV and Cardiovascular Disease: We Need a Mechanism, and We Need a Plan.Disparities in the Quality of Cardiovascular Care Between HIV-Infected Versus HIV-Uninfected Adults in the United States: A Cross-Sectional Study.Underutilization of Statins When Indicated in HIV-Seropositive and Seronegative Women.

P2860

Q34736194-778C220F-493A-440E-9012-2845542E718B Q35064091-B78EA4F6-B87B-4489-B3A9-5D420F2CFACF Q35072103-7BDDB4BE-6C44-4477-B3F2-0DAE5B3101A6 Q35589825-0C86BB62-F63B-49DB-A11B-AF63D3AD4D23 Q36035835-40AD1D82-5E80-46C3-AF3E-9D738DBC7D38 Q36668917-1C0285A8-9B0A-469A-B58C-FDAF57377C82 Q37025385-8449DF1B-BA91-42B4-8C8E-5D259FDCC0C8 Q37225786-6B2CD3DC-9BCD-4860-BDA2-369C53173F6E Q37528500-DC986B53-E68C-4A0D-A35A-59D1F31D8BED Q37661603-5E6B6F0F-55D5-4315-992E-BFE7E88594C8 Q38261508-2BE68C21-1A02-40F8-946D-858F4998BE3C Q39165028-78E25B0E-B2E7-44D8-8757-9035171E223C Q39861096-4A5F953C-9186-430A-B478-64176073349F Q40656708-7D0A0F43-A058-4AB2-B3D2-80683CC2343F Q40876796-2A2FFE94-4609-4BCB-AA63-4C1F987CC519 Q41246280-BAF703C7-BC2B-4834-B5F2-C8F507612EE3 Q42423832-56D1BF1F-2BB5-4FCB-AAC4-C58A08BCF8F7 Q46321167-B113396C-46DF-40FA-A713-E6C4ADFC11DB Q46932672-1C9ABCF6-8AF5-43AB-9A22-37A062BDB9C3

P2860

Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients

http://www.wikidata.org/entity/Q36379615

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Underutilization of aspirin fo ...... se among HIV-infected patients

@ast

Underutilization of aspirin fo ...... se among HIV-infected patients

@en

type

label

Underutilization of aspirin fo ...... se among HIV-infected patients

@ast

Underutilization of aspirin fo ...... se among HIV-infected patients

@en

prefLabel

Underutilization of aspirin fo ...... se among HIV-infected patients

@ast

Underutilization of aspirin fo ...... se among HIV-infected patients

@en

P1433

Q36379615-A2DA722F-942F-424C-98AE-62555DA424FE

P1476

Q36379615-73D8AD7E-B491-4BC2-8B13-149E62C6477D

P2093

Q36379615-02DB9B9C-1E56-4CAB-8396-EE74D12088B8

Q36379615-1C4B9278-A413-4D82-A68B-B3205178E68D

Q36379615-273C99BC-C203-4DDC-B946-4B128C669EF4

Q36379615-DB0C5672-4645-4A52-B144-BAD558EF8AF4

Q36379615-F899EA34-4310-49BB-9F1C-8B2E9A54EA63

Q36379615-FF5ED5CB-CA2B-4594-9E92-8D45582ED3E2

P2860

Q36379615-216B9C09-21BC-49DA-9906-7BC64F60915F

Q36379615-332CE4A4-7172-40AF-82D6-0DBC4EC86875

Q36379615-33D6A308-DA7E-4A48-B4DE-6B90D68CF603

Q36379615-370655D1-21DF-41B7-9B65-F6D7E28D77DE

Q36379615-3BA33780-BDFA-4791-A93D-747178CC8BC0

Q36379615-3EDA3255-D185-4834-A0DC-FF8B16BEE90A

Q36379615-43A8A8AF-6AA6-435C-84F3-F14752C46BBE

Q36379615-4FF6F06B-919E-46AA-8704-7FC105D377DF

Q36379615-588FAC34-300C-415D-A901-827302FB04E6

Q36379615-5B7770D6-01BF-4289-9AB0-2C270F08891E

P304

Q36379615-51A059F5-864B-4F52-9D7E-160278C214D1

P31

Q36379615-F106886B-48D8-49AD-BD11-FA08639E1D3D

P356

Q36379615-C1EE5457-B1D2-4A78-AB19-A5DA3F53D5FD

P407

Q36379615-BEA7A453-3F77-4FD1-B94B-FD42941137A2

P433

Q36379615-B30C4364-98ED-4110-B13D-B18D0EA15E93

P478

Q36379615-E6769A57-DD21-433B-86E1-6996D7427984

P50

Q36379615-9BAA763F-FA41-4BF7-839E-74F04BE04CDA

Q36379615-C78A49BF-DBF0-4426-AB7B-E7C2A34E090D

P577

Q36379615-CEFC740B-5669-4BDA-BA46-C297AAC778EF

P5875

Q36379615-DFE6118D-FE7A-4E7C-8EC1-6FF2CD873ACD

P698

Q36379615-51C90E7E-7835-43D6-973F-B75C47FA5605

P921

Q36379615-2793B5FE-34E2-44A4-AF1F-2456F9B697A2

Q36379615-A6ED25D6-B3C4-4F16-A2F0-EF8EF6FE803B

Q36379615-C48106D8-DCC6-494B-9C42-768336801D8B

P932

Q36379615-833F16A2-418C-471A-88B6-6571306B9B18

P356

P1433

Clinical Infectious Diseases

P1476

Underutilization of aspirin fo ...... se among HIV-infected patients

@en

P2093

Greer A Burkholder

http://www.w3.org/2001/XMLSchema#string

James H Willig

http://www.w3.org/2001/XMLSchema#string

James L Raper

http://www.w3.org/2001/XMLSchema#string

Jorge L Salinas

http://www.w3.org/2001/XMLSchema#string

Michael J Mugavero

http://www.w3.org/2001/XMLSchema#string

Michael S Saag

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Aspirin use for the primary prevention of coronary heart disease in older adults

National study of physician awareness and adherence to cardiovascular disease prevention guidelines

Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study.

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology.

Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV.

Decline in the AIDS and death rates in the EuroSIDA study: an observational study.

Patient reported outcomes in routine care: advancing data capture for HIV cohort research.

P304

1550-1557

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIS752

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P50

Andrew O Westfall

Ashutosh Tamhane

P577

2012-08-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230784076

http://www.w3.org/2001/XMLSchema#string

P698

22942209

http://www.w3.org/2001/XMLSchema#string

P921

prevention of HIV/AIDS

P932

3491860

http://www.w3.org/2001/XMLSchema#string